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Background: The rheolytic thrombectomy are recently introduced for the treatment of
acute thrombosis in peripheral lesions in Korea. The AngioJet (MEDRAD, Warren-
dale, PA, USA) is a dual lumen catheter that uses the principle of the Bernoulli
principle to capture, fragmentate and remove unorganized thrombus. We experienced
10 cases with rheolytic thrombectomty and report them.
Methods: This is a retrospective review from prospectively registered data base of the
patients who underwent rheolytic thrombectomty with AngioJet from Nov 2011 to July
2013. The patients’ clinical characteristics and procedure was reviewed and summarized.
Results: Ten cases were enrolled. The mean age was 59.7 year old and ﬁve were male.
There were 3 cases for acute arterial thrombosis(emboli from atrial ﬁbrillation, acute on
chronic peripheral vascular disease, acute thrombosis of femoral stent with instent
restenosis), 5 cases for acute iliofemoral deep vein thrombosis with May Thurner’s
syndrome, 2 cases for acute mesenteric venous ischemia. There was no mortality.
Technical success rate was 90%. There were 1 distal embolization, 3 hemoglobinuria,
and 1 stent occlusion. For all the arterial lesions, stentings were needed. Two cases
needed additional thrombolysis due to incomplete thrombectomy and four cases needed
iliac vein stenting for venous cases. There were 3 additional thrombolysis. The operating
time for AngioJet was about 5minutes while the mean procedure time was 116minutes.
Conclusion: The rheolytic thrombectomy using AngioJet showed good results in
acute thrombosis in the peripheral lesions and can be considered as an useful alter-
native option to open thrombectomy or thrombolysis.
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Background: Since TASC II revision, indication of EVT for lower limbs has been
expanded. However, the efﬁcacy of the EVT for non-stent zone and complicated le-
sions like popliteal artery has not fully investigated.
Purpose: To clarify the clinical outcome of EVT for popliteal artery lesion in the mid-
term settings.
Methods: From April 2004 to March 2013, consecutive 97 lesions of 66 cases
(including 44 CTOs and 53 non-CTOs) of EVT for popliteal artery were sought
retrospectively. We excluded the contiguous lesions with the superﬁcial femoral artery
and lesions of thrombotic occlusion or aneurysmal rupture. Lesion stenosis was
evaluated just before and after the EVT procedure by cineangiogram with the oper-
ators’ discretion. We re-evaluated the EVT lesions after a year later by duplex ul-
trasound or angiogram as well as ABI measurement. In addition, we investigated the
relationship between the mid-term clinical outcome and the number of BK (below-the-
knee) run-offs at the end of procedures.
Results: Acute procedural success was obtained in 98% lesions. Balloon angioplasty
alone was performed for 90 lesions (95%), and stent implantation was required 5
lesions (5%) due to inadvertent vessel dissection with severe ﬂow limit. One-year
follow-up was accomplishedin 83% (79/95). Overall restenosis rate was 46% (36/79).
Especially, restenosis rate was siginiﬁcantly higher in CTOs than no-CTOs( 60.0% vs.
34.1% p¼0.021). The number of BK run-off at the end of the procedure demonstrated
a trend of inverse relationship with the incidence of mid-term restenosis rate (BK run-
off: 54.8%(/1 vessels) vs. 35.1%(/2 vessels) p¼0.08). With regard to ﬁve stent
lesions, we found the restenosis occurred in two lesions. There was no difference in
lesion characteristics except the deployment site in the popliteal artery. Thus, the stent
was deployed in the middle of the popliteal artery that corresponded to the hinge point
with the bend of the knee joint. As for the rest of 3 cases free from restenosis, stents
were deployed more proximally sparing the hinge point.
Conclusion: Restenosis rate of EVT for the popliteal artery was 46% within 12
months. Especially, CTO lesions demonstrated higher restenosis rate than non-CTO
lesions. Based on the present study, the number of BK run-off yields a trend of inverse
relationship with the incidence of restenosis, though no signiﬁcant difference was
demonstrated. Further, the stenting technique sparing the hinge point of popliteal
artery may contribute to the reduction of restenosis of this “non-stent zone”.TCTAP A-110
Impact Factors of Distal Stent Graft Induced New Entry in Type B Aortic
Dissection
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Background: Stent graft-induced new entry (SINE) is a major complication after
thoracic stent graft implantation in aortic dissection. This devastating complicationJACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/ORAmay cause pseudoaneurysm with possible lethal rupture. Here, we retrospective
analysed our patients receiving stent graft for complicated type B aortic dissection and
tried to ﬁnd the impact factors of SINE.
Methods: From November 2006 to July 2012, 84 patients received thoracic stent graft
implantation +/- cervical bypass due to complicated type B aortic dissection in our
institute. 73 of them had regular post-operative follow up more than 1 year and then were
included in our study. 49 of 73 patients received stent graft implantation as sequence
with proximal deployment ﬁrst and then distal deployment (proximal ﬁrst group). The
other 24 of 73 patients received stent graft implantation as sequence with distal
deployment ﬁrst and then proximal deployment (distal ﬁrst group). 16 of 49 patients in
proximal ﬁrst group and 1/17 patients in distal ﬁrst group developed distal SINE. We
chose 5 items, including longitudinal, transverse and mean diameters, circumference and
area of the true lumen as characters. And we measured these 5 items at proposed
proximal and distal landing zones, and the distal stent graft before and after proce-
dure.With these items, we calculated the taper ratio, prestent grafting and poststent
grafting oversizing ratio and expansion mismatch ratio of distal true lumen to evaluate
the possible impact factors of distal SINE.
Results: The incidence of distal SINE reached signiﬁcant difference between group of
proximal deployment ﬁrst and distal deployment ﬁrst (p¼0.007). In each group, all the
calculated ratios had no signiﬁcant difference. When comparing between two groups,
there was much signiﬁcant difference in the prestent grafting and poststent grafting
oversizing ratio in diameters, circumference and area. (p<0.001)
Conclusion: We found that too much oversizing at distal landing zone should be
avoided to decrease the possibility of distal SINE. Besides, thoracic stent graft im-
plantation as sequence with distal deployment ﬁrst and then proximal deployment
should be executed if possible.TCTAP A-111
Chronic Ostial-proximal Common Iliac Arteries Stenosis or Occlusions Treated
with One Stage Contemporary Delivering of Two Iliac Stents
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Background: Something about 12% of the population is affected with peripheral
vascular disease (PAD). This percentage is markedly increased in special subgroups, like
those with multiple risk factors or with known coronary or cerebral artery disease. About
16% of patients affecting from PAD have aorto-iliac disease and according to the literature
have a poorer general prognosis than those with more distal PAD Trans-Atlantic Inter-
Society Consensus (TASC IIa) lesions involving iliac arteries are best treated with
endovascular therapy and surgery is reserved only if PTA is unsuccessful. Endovascular
stents have become an accepted therapy for patients with iliac occlusive disease. They
have been associated with symptomatic improvement and a greater than 90% patency rate.
Methods: In the region of Yambol (south-eastern Bulgaria) from the beginning of
2012 we organise an interdisciplinary team with participation of Italian specialists for
early clinical and non-invasive diagnosis, hospitalization for interventional or surgical
treatment and consequence clinical follow-up of the patients affected with PAD. The
core of the team consists of interventional cardiologist, vascular surgeon and the patient
general practitioner. Any decision for treatment either surgical or interventional was
done in complete consensus between the surgeon and the interventional cardiologist.
From January 2012 to July 2013 we had 6 patients (4 males 66,7%, mean age
68,3 y) with bilateral ostial-proximal stenosis or ostial occlusions of both common
iliac arteries (Fig 1a). Two of them have had total ostial occlusions of both iliac ar-
teries (Fig.1,a) and the rest 4 (66%) have had severe ostial stenosis of both commonL/Peripheral Vascular Intervention (Non-carotid, Non-neurovascular) S31
